Best Evidence to Support Regulatory Decision-Making

Sep-13

AUTHORS : Kevin Blake, European Medicines Agency – Email: kevin.blake@ema.europa.eu OR Ana Hidalgo-Simon, Advanced Therapies Office, Human Medicines Division, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands – Email: ana.hidalgo-simon@ema.europa.eu OR Peter Arlett, Head of Pharmacovigilance and Epidemiology Department, European Medicines Agency – Email: Peter.Arlett@ema.europa.eu – Profile: https://www.efpia.eu/miscellaneous-items/people/peter-arlett/

JOURNAL : Drug Safety

REFERENCE: 36(9):866

DOI : 10.1007/s40264-013-0087-x

Best Evidence to Support Regulatory Decision-Making

More publications

The risk of immune-mediated inflammatory diseases following exposure to childhood maltreatment: a retrospective cohort study using UK primary care data

A double-Cox model for non-proportional hazards survivalanalysis with frailty

Regression discontinuity designs for time-to-event outcomes: An approach using accelerated failure time models